ECarboX protocol
Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Therapy Context: Research Results